News | November 20, 2012

GE Gains Health Canada Approval for FREEdom Edition Cardiac Spectral CT

November 15, 2012 – GE Healthcare Canada announced Health Canada clearance of its new cardiac imaging platform, the Discovery* CT750 HD FREEdom Edition. Addressing the main challenges of cardiac imaging – coronary motion, calcium blooming, plaque composition and accurate myocardial perfusion – the FREEdom Edition is designed to provide a new level of cardiac CT performance.

Discovery CT750 HD FREEdom Edition offers physicians capabilities that are designed to overcome some of the current limitations of cardiac CT. Based on exclusive FREEdom technologies (Fast Registered Energies & ECG), this innovative system represents a three-prong solution to the challenges in traditional cardiac CT: (1) Motion FREEdom, with intelligent motion correction via SnapShot* Freeze; (2) Calcium FREEdom, with enhanced coronary visualization using Gemstone* Spectral Imaging (GSI) Cardiac; and (3) Horizon FREE opportunities, going beyond today's clinical information with plaque material composition assessment and information for accurate perfusion calculations. 

SnapShot Freeze, one of FREEdom’s innovative technologies, can help significantly reduce coronary motion and overcome some of the limitations of all hardware-only solutions. By precisely detecting vessel motion and velocity, SnapShot* Freeze can determine actual vessel position and intelligently correct the effects of motion during cardiac CT exams. Engineering evaluation of SnapShot* Freeze intelligent motion correction has demonstrated that SnapShot* Freeze can achieve a 58msec Equivalent Gantry Rotation Speed, which is 4 to 6 times faster than gantry rotation speed alone. This translates to a 29msec Effective Temporal Resolution which achieves a Cardiac CT temporal sampling similar to the frame rate of a cath lab.

FREEdom Edition has the potential to significantly improve coronary artery imaging with CT,” said Dr. Jonathon Leipsic, Head of Radiology, Providence Health, St. Paul’s Hospital in Vancouver. “By intelligently reducing motion artifact in CT images, SnapShot* Freeze improves visualization, which may allow for reduction in the number of non-interpretable segments and increases reader confidence of CCTA.”

HD FREEdom’s first U.S. installation at the University of Washington follows approximately two dozen installations in Europe and Japan where physicians are currently using SnapShot* Freeze and GSI Cardiac in routine practice for coronary evaluation, and pushing the horizons of Cardiac CT in plaque composition and myocardial perfusion assessment.

The system is also the first Cardiac Spectral CT scanner that merges GE’s pioneering SnapShot* Pulse technology with GSI’s fast kV switching allowing for a registered spectral CT dataset. Spectral CT takes CT beyond anatomy to create images of quantitative material density, which can then be synthesized into monochromatic energies. Monochromatic images have key advantages in virtually beam-hardening artifact free images, and improved contrast-to-noise at a given dose. And “Calcium FREEdom” means that, now coronary images with calcium suppression are possible for challenging patients with high calcium burden. Additionally, GSI Cardiac enables investigations into new horizons of CT coronary plaque assessment and quantitative myocardial perfusion.

GE’s Discovery CT750 HD leads the industry in cardiac CT spatial resolution at 18.2 lp/cm^. This level of resolution helps physicians make a confident diagnosis and accurately quantify stenoses in coronary vessels by displaying reduction in calcium blooming compared to standard resolution. 

GE Healthcare’s continued leadership in cardiac imaging was recently highlighted when the Discovery CT750 HD was included in the first ever fully positive recommendation from the UK’s National Institute for Health and Clinical Excellence (NICE) Diagnostic Assessment Programme, which aims to ensure the National Health Service can rapidly and consistently adopt clinically and cost effective technologies. NICE recommended the Discovery* CT750 HD scanner as an option for first line cardiac imaging of the coronary arteries in people with suspected coronary artery disease.

“We believe the traditional challenges of cardiac CT are in large part beatable with a smarter software and electronic approach,” said Peter Robertson, vice president and general manager for GE Healthcare, Canada. “FREEdom Edition offers physicians a new tool to help overcome coronary motion, and various artifacts that may stand in the way of a highly accurate, confident cardiac diagnosis in a variety of clinical settings.” 

FREEdom Edition is built on the robust and proven Discovery CT750 HD platform. Installed in hundreds of medical institutions around the globe, this platform is powered by GE's exclusive HD and low dose technologies, including GSI for additional information for aiding in lesion characterization and proven Adaptive Statistical Iterative Reconstruction (ASiR) dose-optimizing technology already used on over 20 million scans at 1,800 sites worldwide. 

For more information: www.gehealthcare.com

Related Content

Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Key Patient Preparations for a CT Scan
News | Computed Tomography (CT) | September 05, 2018
The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
Videos | Computed Tomography (CT) | July 23, 2018
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiova
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
FFR-CT may soon replace invasive angiography for coronary lesion assessment. #EuroPCR 

Anexample of a clinical case of CT-FFR, which can derive the FFR numbers for their entire coronary tree using a noninvasive CT scan.

Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving no
James Min Named Editor-in-Chief of Journal of Cardiovascular Computed Tomography
News | Computed Tomography (CT) | May 01, 2018
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of...
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
April 18, 2018 — The U.S.
Overlay Init